Fully closed-loop subcutaneous insulin delivery improves glycemic control in people undergoing elective surgery.
A new study has found that fully closed-loop subcutaneous insulin delivery is more beneficial than standard insulin therapy for individuals having elective surgery.
During a randomised controlled trial, the team of researchers examined 45 adults whilst they underwent different surgeries, such as orthopaedic, neuro, thoracic, abdominal and vascular surgery.
As part of the study, 50% of the participants received fully closed-loop insulin delivery with fast-acting insulin aspart and the other half received standard insulin therapy.
The results stated: “The mean proportion of time that sensor glucose was in the target range was 76.7 ± 10.1% in the closed-loop group and 54.7 ± 20.8% in the control group (mean difference 22.0 percentage points [95% CI 11.9; 32.0%]; P < 0.001).
“No episodes of severe hypoglycaemia (<3.0 mmol/L) or hyperglycaemia with ketonemia or any study-related adverse events occurred in either group, reported David Herzig, of Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, University Hospital of Bern, Switzerland, and colleagues.”
Read the study here.
Photo by Vidal Balielo Jr by Pexels